iShares U.S. Medical Devices UCITS ETF (AMS:UMDV)
6.78
+0.01 (0.20%)
Jul 1, 2025, 5:35 PM CET
12.77% (1Y)
Assets | 173.94M |
Expense Ratio | 0.25% |
PE Ratio | 30.23 |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Ex-Dividend Date | n/a |
Payout Frequency | n/a |
Payout Ratio | n/a |
1-Year Return | +12.77% |
Volume | 30,223 |
Open | 6.78 |
Previous Close | 6.76 |
Day's Range | 6.74 - 6.78 |
52-Week Low | 5.73 |
52-Week High | 7.07 |
Beta | 1.21 |
Holdings | 55 |
Inception Date | Aug 3, 2020 |
About UMDV
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the Dow Jones U.S. Select Medical Equipment Capped 35/20 Index.
Asset Class Equity
Category Health Care
Region North America
Stock Exchange Euronext Amsterdam
Ticker Symbol UMDV
Provider iShares
Index Tracked Dow Jones U.S. Select Medical Equipment Capped 35/20 Index
Performance
UMDV had a total return of 12.77% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.26%.
Top 10 Holdings
83.04% of assetsName | Symbol | Weight |
---|---|---|
Abbott Laboratories | ABT | 18.72% |
Intuitive Surgical, Inc. | ISRG | 15.32% |
Boston Scientific Corporation | BSX | 12.62% |
Stryker Corporation | SYK | 10.82% |
Medtronic plc | MDT | 8.83% |
Becton, Dickinson and Company | BDX | 3.92% |
Edwards Lifesciences Corporation | EW | 3.67% |
IDEXX Laboratories, Inc. | IDXX | 3.42% |
ResMed Inc. | RMD | 3.00% |
GE HealthCare Technologies Inc. | GEHC | 2.73% |